This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Sekisui Diagnostics LLC. Active years: 2012-2014.
Location History:
- Prince Edward Island, CA (2012)
- Price Edward Island, CA (2014)
Company Filing History:
Years Active: 2012-2014
Title: Michael Bulger: Innovator in Acetaminophen Assays
Introduction
Michael Bulger is a notable inventor based in Prince Edward Island, Canada. He has made significant contributions to the field of medical diagnostics, particularly in the development of assays for acetaminophen. With a total of 2 patents to his name, Bulger's work has the potential to enhance the accuracy and reliability of acetaminophen level monitoring.
Latest Patents
Bulger's latest patents include an innovative acetaminophen assay and an acetaminophen assay kit. The acetaminophen assay provides a reliable method for the quantitative determination of p-aminophenol in an aqueous sample. This rapid enzyme-based assay employs a xylenol chromophore and a catalyst, which is preferably a weak oxidizer. The assay is designed to deliver reliable results regardless of the presence of N-acetylcystiene (NAC), making it particularly useful for monitoring acetaminophen levels during NAC treatment. Additionally, methods and kits for determining acetaminophen concentration in an aqueous sample are also included in his inventions.
Career Highlights
Michael Bulger is currently associated with Sekisui Diagnostics LLC, where he continues to innovate in the field of diagnostics. His work has been instrumental in advancing the methodologies used for acetaminophen testing, which is crucial for patient safety and treatment efficacy.
Collaborations
Bulger collaborates with Jan Holinsky, contributing to the development of diagnostic tools that can significantly impact patient care.
Conclusion
Michael Bulger's contributions to acetaminophen assays exemplify the importance of innovation in medical diagnostics. His patents not only enhance the reliability of acetaminophen monitoring but also reflect his commitment to improving healthcare outcomes.